[HTML][HTML] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - ncbi.nlm.nih.gov
Background Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …

[PDF][PDF] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - researchgate.net
Background: Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …

Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …

[PDF][PDF] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - academia.edu
Background: Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …

Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer.

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - europepmc.org
Background Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …

[PDF][PDF] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - cdn.amegroups.cn
Background: Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …

[引用][C] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - cir.nii.ac.jp
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in
unresectable pancreatic cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[HTML][HTML] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - jgo.amegroups.org
Background: Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …

Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

T Muranaka, M Kuwatani, Y Komatsu… - Journal of …, 2017 - jgo.amegroups.org
Background: Irinotecan, oxaliplatin and leucovorin-modulated fluorouracil (FOLFIRINOX)
and the combination regimen of gemcitabine and nanoparticle albumin-bound paclitaxel …